Preparation of high bioactivity multilayered bone-marrow mesenchymal stem cell sheets for myocardial infarction using a 3D-dynamic system
Source abstract
Abstract
Cell sheet techniques offer a promising future for myocardial infarction (MI) therapy; however, insufficient nutrition supply remains the major limitation in maintaining stem cell bioactivity in vitro. In order to enhance cell sheet mechanical strength and bioactivity, a decellularized porcine pericardium (DPP) scaffold was prepared by the phospholipase A2 method, and aspartic acid was used as a spacer arm to improve the vascular endothelial growth factor crosslink efficiency on the DPP scaffold. Based on this scaffold, multilayered bone marrow mesenchymal stem cell sheets were rapidly constructed, using RAD16-I peptide hydrogel as a temporary 3D scaffold, and cell sheets were cultured in either the 3D-dynamic system (DCcs) or the traditional static condition (SCcs). The multilayered structure, stem cell bioactivity, and ultrastructure of DCcs and SCcs were assessed. The DCcs exhibited lower apoptosis, lower differentiation, and an improved paracrine effect after a 48 h culture in vitro compared to the SCcs. Four groups were set to evaluate the cell sheet effect in rat MI model: sham group, MI control group, DCcs group, and SCcs group. The DCcs group improved cardiac function and decreased the infarcted area compared to the MI control group, while no significant improvements were observed in the SCcs group. Improved cell survival, angiogenesis, and Sca-1+ cell and c-kit+ cell amounts were observed in the DCcs group. In conclusion, the DCcs maintained higher stem cell bioactivity by using the 3D-dynamic system to provide sufficient nutrition, and transplanting DCcs significantly improved the cardiac function and angiogenesis. Statement of significance This study provides an efficient method to prepare vascular endothelial growth factor covalent decellularized pericardium scaffold with aspartic acid, and a multilayered bone marrow mesenchymal stem cell (BMSC) sheet is constructed on it using a 3D-dynamic system. The dynamic nutrition supply showed a significant benefit on BMSC bioactivity in vitro, including decreasing cell apoptosis, reducing stem cell differentiation, and improving growth factor secretion. These favorable bioactivity improved BMSC survival, angiogenesis, and cardiac function of the infarcted myocardium. The study highlights the importance of dynamic nutrition supply on maintaining stem cell bioactivity within cell sheet, and it stresses the necessity and significance of setting a standard for assessing cell sheet products before transplantation in the future application.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Tissue Engineering and Regenerative Medicine · Electrospun Nanofibers in Biomedical Applications · Mesenchymal stem cell research
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (48)
Show source-provided references
1. Bone Marrow Mesenchymal Stem Cells (BM-MSCs) improve heart function in swine myocardial infarction model through paracrine effects10.1038/srep31528 ↗
2. Safety and efficacy of cardiopoietic stem cells in the treatment of post-infarction left-ventricular dysfunction – From cardioprotection to functional repair in a translational pig infarction model10.1016/j.biomaterials.2016.11.029 ↗
3. Monolayered mesenchymal stem cells repair scarred myocardium after myocardial infarction10.1038/nm1391 ↗
4. Comparison of angiogenic potential between prevascular and non-prevascular layered adipose-derived stem cell-sheets in early post-transplanted period10.1002/jbm.a.34707 ↗
5. Flexible shape-memory scaffold for minimally invasive delivery of functional tissues10.1038/nmat4956 ↗
6. Baculovirus-transduced, VEGF-expressing adipose-derived stem cell sheet for the treatment of myocardium infarction10.1016/j.biomaterials.2013.09.080 ↗
7. Targeted genome engineering to control VEGF expression in human umbilical cord blood-derived mesenchymal stem cells: potential implications for the treatment of myocardial infarction10.1002/sctm.16-0114 ↗
8. Thermoresponsive poly(glycidyl ether) brushes on gold: surface engineering parameters and their implication for cell sheet fabrication10.1016/j.actbio.2017.06.029 ↗
9. Cell sheets prepared via gel-sol transition of calcium RGD-alginate10.1016/j.actbio.2015.10.046 ↗
10. Nitric oxide releasing hydrogel enhances the therapeutic efficacy of mesenchymal stem cells for myocardial infarction10.1016/j.biomaterials.2015.04.046 ↗
11. Enhanced cell survival and paracrine effects of mesenchymal stem cells overexpressing hepatocyte growth factor promote cardioprotection in myocardial infarction10.1016/j.yexcr.2016.03.024 ↗
12. Compared to the amniotic membrane, Wharton's jelly may be a more suitable source of mesenchymal stem cells for cardiovascular tissue engineering and clinical regeneration10.1186/s13287-017-0501-x ↗
13. Impact of cell composition and geometry on human induced pluripotent stem cells-derived engineered cardiac tissue10.1038/srep45641 ↗
14. Epicardial delivery of collagen patches with adipose-derived stem cells in rat and minipig models of chronic myocardial infarction10.1016/j.biomaterials.2013.09.083 ↗
15. Multilayered adipose-derived regenerative cell sheets created by a novel magnetite tissue engineering method for myocardial infarction10.1016/j.ijcard.2014.06.034 ↗
16. A tissue engineering approach to progenitor cell delivery results in significant cell engraftment and improved myocardial remodeling10.1634/stemcells.2007-0132 ↗
17. Three-dimensional cardiac tissue fabrication based on cell sheet technology10.1016/j.addr.2015.05.002 ↗
18. Quality and freshness of human bone marrow-derived mesenchymal stem cells decrease over time after trypsinization and storage in phosphate-buffered saline10.1038/s41598-017-01315-0 ↗
19. Preparation and characterization of acellular porcine pericardium for cardiovascular surgery10.3906/biy-1510-44 ↗
20. The use of phospholipase A(2) to prepare acellular porcine corneal stroma as a tissue engineering scaffold10.1016/j.biomaterials.2009.03.003 ↗
21. Reconstruction of auto-tissue-engineered lamellar cornea by dynamic culture for transplantation: a rabbit model10.1371/journal.pone.0093012 ↗
22. Using acellular porcine limbal stroma for rabbit limbal stem cell microenvironment reconstruction10.1016/j.biomaterials.2011.07.012 ↗
23. Construction of the recellularized corneal stroma using porous acellular corneal scaffold10.1016/j.biomaterials.2011.05.084 ↗
24. Using genipin-crosslinked acellular porcine corneal stroma for cosmetic corneal lens implants10.1016/j.biomaterials.2012.06.080 ↗
25. Promotion of adhesion and proliferation of endothelial progenitor cells on decellularized valves by covalent incorporation of RGD peptide and VEGF
26. Reconstruction of highly proliferative auto-tissue-engineered lamellar cornea enhanced by embryonic stem cell10.1089/ten.tec.2014.0481 ↗
27. New colloidal fabrication of bioceramics with controlled porosity for delivery of antibiotics10.1007/s10853-016-0133-z ↗
28. Effects of glucose and its modulation by insulin and estradiol on BMSC differentiation into osteoblastic lineages10.1139/o05-163 ↗
29. Comparison of rat mesenchymal stem cells derived from bone marrow, synovium, periosteum, adipose tissue, and muscle10.1007/s00441-006-0308-z ↗
30. Effect of simvastatin on collagen I deposition in non-infarcted myocardium: role of NF-kappaB and osteopontin10.1139/Y10-075 ↗
31. PET of glucagonlike peptide receptor upregulation after myocardial ischemia or reperfusion injury10.2967/jnumed.112.109413 ↗
32. Bioinspired synthesis of mineralized collagen fibrils10.1021/cg800252f ↗
33. Dendrimer crosslinked collagen as a corneal tissue engineering scaffold: mechanical properties and corneal epithelial cell interactions10.1016/j.biomaterials.2006.04.022 ↗
34. The extracellular matrix: not just pretty fibrils10.1126/science.1176009 ↗
35. Functionalized self-assembling peptide nanofiber hydrogels mimic stem cell niche to control human adipose stem cell behavior in vitro10.1016/j.actbio.2013.01.027 ↗
36. Transplantation of marrow-derived cardiac stem cells carried in designer self-assembling peptide nanofibers improves cardiac function after myocardial infarction10.1016/j.bbrc.2010.07.031 ↗
37. Roles of diffusion dynamics in stem cell signaling and three-dimensional tissue development10.1089/scd.2017.0066 ↗
38. Three-dimensional functional human myocardial tissues fabricated from induced pluripotent stem cells10.1002/term.1995 ↗
39. Epicardial adipose stem cell sheets results in greater post-infarction survival than intramyocardial injections10.1093/cvr/cvr099 ↗
40. Use of lipophilic near-infrared dye in whole-body optical imaging of hematopoietic cell homing10.1117/1.2364903 ↗
41. Epicardial placement of mesenchymal stromal cell-sheets for the treatment of ischemic cardiomyopathy; in vivo proof-of-concept study10.1038/mt.2014.110 ↗
42. The use of scaffold-free cell sheet technique to refine mesenchymal stromal cell-based therapy for heart failure10.1038/mt.2013.9 ↗
43. Adult c-kit(pos) cardiac stem cells are necessary and sufficient for functional cardiac regeneration and repair10.1016/j.cell.2013.07.039 ↗
44. Endogenous cardiac stem cells10.1016/j.pcad.2007.03.005 ↗
45. Sca-1-positive cardiac stem cell migration in a cardiac infarction model10.1007/s10753-013-9600-8 ↗
46. Mobilization of sca1/flk-1 positive endothelial progenitor cells declines in apolipoprotein E-deficient mice with a high-fat diet10.1016/j.jjcc.2015.02.008 ↗
47. Fibroblast growth factor-9 activates c-Kit progenitor cells and enhances angiogenesis in the infarcted diabetic heart10.1155/2016/5810908 ↗
48. The effects of mesenchymal stem cells on c-kit up-regulation and cell-cycle re-entry of neonatal cardiomyocytes are mediated by activation of insulin-like growth factor 1 receptor10.1007/s11010-009-0170-x ↗